Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/08 → 31/03/11 |
Funding
- Cancer Australia: A$294,657.86
- Prostate Cancer Foundation of Australia: A$362,454.59
Preclinical and clinical evaluation of an antibody therapeutic targeting prostate carcinoma
- Lackmann, Martin (Primary Chief Investigator (PCI))
- Boyd, Andrew Wallace (Chief Investigator (CI))
- Scott, Andrew (Chief Investigator (CI))
Project: Research